Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary …

Importance Pulmonary embolism (PE) is characterized by occlusion of blood flow in a
pulmonary artery, typically due to a thrombus that travels from a vein in a lower limb. The …

determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

A compelling body of evidence points to pulmonary thrombosis and thromboembolism as a
key feature of COVID-19. As the pandemic spread across the globe over the past few …

Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …

Aims To systematically assess late outcomes of acute pulmonary embolism (PE) and to
investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively …

Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …

Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism,
is a chronic illness that affects nearly 10 million people every year worldwide. Strong …

Venous thromboembolism (VTE) including pulmonary embolism (PE) and deep vein
thrombosis (DVT) is one of the leading causes of preventable cardiovascular disease in the …

Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term
complication of acute pulmonary embolism (PE). Untreated CTEPH is fatal, but, if diagnosed …